Pharma & Healthcare – the latest on Ninth Circuit, Health Insurance and more.
Ninth Circuit Rejects Presumption of Irreparable Harm for Trademark Owners by Eric Ball, Sebastian Kaplan, Jedediah Wakefield Published on jdsupra
Reversing decades of precedent, on Monday the Ninth Circuit ruled that trademark owners no longer enjoy a presumption of irreparable harm when seeking a preliminary injunction. As we wrote last year, the presumption of irreparable harm had been in doubt in light of Supreme Court precedent in the patent context… [ Read More ]
Health Insurance Exchanges And The Innovator’s Dilemma–Is The Future Costovation? by Stephen Wunker Published on jdsupra
It’s a heady time in the U.S. health insurance industry. Over 30 million Americans are expected to acquire coverage as the Affordable Care Act takes effect, yet the boon of new customers is offset by a gnawing fear that profit margins will vanish. Due to the ACA and economic pressures, health insurers that have thrived since the Second World War now face tough choices, and their responses will shape the future of healthcare overall… [ Read More ]
How Risperdal Whistle-Blowers Made Millions From J&J by David Voreacos & Sophia Pearson Published on Bloomberg
Judy Doetterl was a sales representative for Johnson & Johnson in 2004 when federal agents placed a hidden recording device on her and sent her to tape marketing presentations at a national company sales meeting…. [ Read More ]
Live Industry News
Follow @ACI_Pharma & @ACI_Health
Join ACI Pharmaceuticals/Biotech/Life Sciences Experts
Join ACI Healthcare: Legal, Regulatory, and Compliance Experts
Related Events
